Can IP Waivers Resolve Vaccine Inequity?
Dr. Lindsay Newman, Director of Economics & Country Risk, IHS Markit
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
With glaring inequities in the supply and distribution of vaccines, the Biden administration has backed a plan to waive intellectual property rights for Covid-19 vaccines and treatments. We speak to Dr. Lindsay Newman, Director of Economics & Country Risk from IHS Markit on whether this could provide a solution to help end the pandemic.
Image Credit: Shutterstock.com
Produced by: Shazana Mokhtar
Presented by: Khoo Hsu Chuang, Philip See
Download the BFM mobile app. Stay at home and stay up-to-date.